# Adjunctive Steroid Combination in Ocular Trauma (ASCOT) Study

> **NCT02873026** · PHASE3 · COMPLETED · sponsor: **Moorfields Eye Hospital NHS Foundation Trust** · enrollment: 300 (actual)

## Conditions studied

- Eye Injury Trauma

## Interventions

- **DRUG:** Triamcinolone Acetonide

## Key facts

- **NCT ID:** NCT02873026
- **Lead sponsor:** Moorfields Eye Hospital NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2020-03-31
- **Final completion:** 2021-01-31
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2021-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02873026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02873026, "Adjunctive Steroid Combination in Ocular Trauma (ASCOT) Study". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02873026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
